spacer

CDC HomeHIV/AIDS > Topics > Statistics and Surveillance > Software > APIDS > Manual

APIDS Manual
space
arrow About this Data Set
space
arrow Assurance of Confidentiality
space
arrow Section 1
space
arrow Section 2
space
arrow Section 3
space
arrow Appendix A
space
arrow Appendix B
space
arrow Appendix C
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
AIDS Surveillance in the United States
spacer
spacer

Background

In 1981, after early reports of Pneumocystis carinii pneumonia, Kaposi's sarcoma, and other opportunistic infections in young homosexual men in Los Angeles, New York, and San Francisco, the Centers for Disease Control and Prevention (CDC) began surveillance for a newly recognized constellation of diseases, now termed the acquired immunodeficiency syndrome (AIDS). CDC developed a surveillance case definition for this syndrome and initially received case reports directly from health care providers and state and local health departments. As the epidemic spread, state and local health departments assumed responsibility for AIDS surveillance, and by 1985 all states had regulations requiring physicians and other health care providers to report AIDS cases directly to the state or local health department. These health departments then share the reports with CDC, which produces the national AIDS surveillance data set.

The goals of AIDS surveillance have been to monitor both trends in AIDS cases and the scope of severe morbidity due to infection with the human immunodeficiency virus (HIV). AIDS surveillance data are used to allocate resources for patient care, target HIV prevention programs, and evaluate the impact of public health recommendations. Advances in the understanding of the epidemiology and manifestations of HIV infection and changing diagnostic practices, however, present multiple challenges to those analyzing and interpreting the AIDS surveillance data. The following are a few examples:

  • A wide variety of persons are at risk for HIV, including men who have sex with men, injecting drug users, person who received a transfusion or who were tissue transplant recipients before March 1985, heterosexual partners of infected persons, children born to infected mothers, and persons with mucous membrane or percutaneous exposure to blood or body fluids of infected persons (e.g., health care workers). Because men who have sex with men comprise such a large proportion of the total number of AIDS cases, trends in this subgroup will overshadow those in other groups unless the data are examined separately. Analysis of data, without regard to specific subgroups, may conceal information or lead to misinterpretation of the data.

  • The etiologic agent of AIDS, HIV, has been identified, and diagnostic tests for infection with this virus have been developed. As a result, the surveillance of AIDS, initially dependent on the presence of certain indicator diseases specific for the infection, was expanded in 1985, 1987, and 1993 to include additional conditions (some conditions may be less specific for HIV infection) in the presence of laboratory evidence for infection, and in 1993 to include HIV-infected persons with laboratory evidence of severe immunosuppression. The addition of these conditions to the AIDS case definition has affected trends in reported AIDS cases, as well as trends in reporting of AIDS-defining opportunistic conditions.

  • Diagnostic practices have changed over time and vary geographically. AIDS is now a common diagnosis in many hospitals and clinics, and definitive diagnostic tests for manifestations of HIV infection (e.g., Pneumocystis carinii pneumonia or esophageal candidiasis) may not be done. HIV testing is not available for all patients and some patients choose not to be tested. Geographic variations in diagnostic practices and surveillance procedures, and changes over time could markedly affect trends in AIDS surveillance.

Return to Manual

Source of AIDS Surveillance Data

CDC maintains national AIDS surveillance through receipt of AIDS case reports submitted by individual state and local health departments. Health departments report cases electronically through a CDC-developed microcomputer system. All 50 states, the District of Columbia, U.S. dependencies and possessions, and independent nations in free association with the United States (Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, the Republic of Palau, the Republic of the Marshall Islands, the Commonwealth of the Northern Mariana Islands, and the Federated States of Micronesia) report AIDS cases to CDC.

Although state and local health departments share AIDS surveillance data with CDC, the responsibility and authority for AIDS surveillance rests with the individual health departments. Like any reportable disease, the completeness of AIDS reporting reflects how actively health departments solicit case reports. Historically, disease surveillance systems have been categorized as passive or active, i.e., health departments may passively receive case reports from health care providers, depending on health care providers to know and comply with reporting requirements; or they may actively contact and interact with health care facilities or individual providers to stimulate disease reporting, sometimes directly assuming the primary responsibility of reporting cases from large or high-volume institutions.

CDC provides funding and technical assistance to health departments to actively stimulate AIDS case reporting and has encouraged them to take an active rather than passive approach to AIDS surveillance. Through surveillance cooperative agreements supported by CDC, health departments are encouraged to identify health care facilities that serve AIDS patients and work closely with these facilities to encourage reporting. They are also encouraged to send newsletters to health care providers and attend professional organization meetings, and to use other data sources to identify AIDS cases, including death certificates, laboratory reports, and tuberculosis and tumor registries. States vary in the structure and organization of their surveillance systems and, therefore, in the completeness of their case reporting (see below).

Return to Manual

Case Definition

Before HIV was identified as the etiologic agent for AIDS, CDC defined a case of AIDS (for surveillance purposes) as a disease, at least moderately indicative of a defect in cell-mediated immunity, occurring in a person with no known cause for diminished resistance to the disease. Such diseases included Pneumocystis carinii pneumonia, Kaposi's sarcoma, and many other serious opportunistic infections (see American Journal of Medicine, March 1984, pages 493-500). With identification of HIV as the causative agent for AIDS and the availability of laboratory tests to detect HIV antibody, the case definition was expanded to reflect an increased understanding of HIV infection in 1985 (see CDC's Morbidity and Mortality Weekly Report, June 28, 1985, pages 373-375) and in 1987 (see Morbidity and Mortality Weekly Report, August 14, 1987, supplement, pages 3S-15S). These revisions applied to persons with laboratory evidence for HIV infection. Among diseases added in 1985 were disseminated histoplasmosis, chronic isosporiasis, and certain non-Hodgkin's lymphomas. Among those added in 1987 were extrapulmonary tuberculosis, HIV encephalopathy, and HIV wasting syndrome. In children, recurrent, serious bacterial infections were also added. In addition, the 1987 revision allowed certain indicator diseases to be diagnosed presumptively based on clinical presentation rather than "confirmed" by laboratory or diagnostic methods.

To be consistent with standards of medical care for HIV-infected persons and to more accurately reflect the number of persons with severe HIV-related immunosuppression who are at highest risk for HIV-related morbidity and most in need of close medical follow-up, the surveillance definition was expanded on January 1, 1993 (see CDC's Morbidity and Mortality Weekly Report, Recommendations and Reports, December 18, 1992). This expansion includes all HIV-infected adults and adolescents who have less that 200 CD4+ T-lymphocytes/µL or a CD4+ T-lymphocyte percent of total lymphocytes less than 14, or who have been diagnosed with pulmonary tuberculosis, invasive cervical cancer, or recurrent pneumonia. The addition of pulmonary tuberculosis, recurrent pneumonia, and invasive cervical cancer in HIV-infected adults and adolescents to the 23 clinical conditions listed in the 1987 surveillance definition reflects their documented or potential importance in the HIV epidemic.

While the reported incidence of AIDS increased only 3 to 4 percent as a result of the 1985 revision, the 1987 revision greatly increased the numbers of reported cases. Roughly one fourth of all adults/adolescents who were both diagnosed and reported in the year following the 1987 revision were reported based only on the additional criteria included in the 1987 revision. Furthermore, the proportion of cases meeting only the revised criteria was higher in Hispanics and non-Hispanic blacks than in non-Hispanic whites, higher in heterosexual injecting drug users, and lower in men who have sex with men. The 1993 revision has had substantial impact on the number of reported cases. The immediate increase in case reporting was largely attributed to the addition of severe immunosuppression to the definition; a smaller impact was due to the addition of pulmonary tuberculosis, recurrent pneumonia, and invasive cervical cancer, since many persons with these diseases also have a CD4+ T-lymphocyte count of less than 200 cells/µL. The early effects of expanded surveillance were greater than long-term effects because prevalent as well as incident cases of immunosuppression were reported after implementation of the expanded surveillance case definition. In recent years, the effect on the number of reported cases has been smaller. Due to the large number of cases reported based on criteria in only the revised case definitions and to the inconsistent use of the revised case definitions in different populations, analyses of trends in AIDS cases must take these revisions into account.

Return to Manual

Case report form

Separate case report forms are used for pediatric patients (patients less than 13 years of age at the time of diagnosis) and adult/adolescent patients (patients 13 years of age or older at the time of diagnosis). Although the forms are similar, the pediatric form includes behavioral risk information on the child's mother. These forms are completed by the health care provider or by the AIDS surveillance staff in the local or state health department. In addition, a laboratory report of an AIDS-defining condition sent to health departments may initiate a case report. In these cases, follow-up with the health care provider is required to obtain complete information.

Names are retained by the state or local health department and are converted to an alpha-numeric code called “soundex” for use by CDC. CDC does not receive names of persons with AIDS. Because more than one state may report an individual case, CDC screens reported cases by soundex code, date of birth, sex, and state of residence to cull presumed duplicate reports. States also cooperate in this process by reporting out-of-jurisdiction cases to the patient's state of residence.

The variables available on the AIDS data set are listed in the next section. However, a few deserve special comment.

  • Vital status. Patients survive for a variable amount of time following the diagnosis of AIDS. Because death usually occurs after the initial report to CDC, case reports may not be updated to reflect the change in vital status. As a result, reporting of deaths among AIDS patients may be delayed or incomplete. However, states are required to perform periodic reviews of death certificates and state death registries to identify unreported cases, and to update vital status of known cases. In addition, 16 states participated in a special project to match their case registries to the National Death Index to assess the completeness of reporting and to identify deaths among cases that died out-of-jurisdiction.

  • Exposure category. Some patients may have more than one mode of exposure to HIV. For surveillance purposes, AIDS cases are counted only once in a hierarchy of exposure categories. Persons with more than one reported mode of exposure are listed in the category that appears first in the exposure hierarchy, except for men with both a history of sexual contact with other men and injecting drug use. They make up a separate exposure category.

  • AIDS definition category. Patients may develop additional conditions indicative of AIDS after their initial AIDS diagnosis. The case report form may not be updated to reflect additional conditions. Some persons reported as meeting only the immunologic criteria may have concurrent or prior opportunistic infections or conditions that are not included in the case report. Therefore, cases reported as meeting only the criteria added to the case definition in 1993 may include persons who meet the criteria in 1987 definition.

  • Date of diagnosis. CDC collects dates of diagnosis for each AIDS-indicator disease, and, for patients with severe immunosuppression, the date of the CD4+ T-lymphocyte test. From this information, a single date of diagnosis is calculated for each patient; it is the earliest of these dates.

Return to Manual

Delay in Reporting

The timeliness of AIDS case reporting to CDC is dependent on a number of factors, including the volume of cases reported from a state or locality, the cooperation of health care providers and medical institutions, the availability of staff to complete case report forms, and changes in the case definition. In many instances initial case reports are incomplete and require additional follow-up by state and local health department staff, including reviews of other record systems and contact with health care providers.

Based on estimates calculated using AIDS surveillance data reported between 1995 and 2000, about 50 percent of all cases were reported to CDC within 4 months of the date of diagnosis, but about 20 percent were reported more than 1 year after diagnosis. Delays vary widely among geographic, age, exposure, sex, and racial/ethnic categories. They are substantially longer for pediatric cases and shorter for AIDS cases previously reported with HIV infection, for example. Due to the reporting delay, the number of cases diagnosed during any period often exceeds the number reported during that period. This is particularly important in examining trends over time, since many cases in recent periods of time will not yet be reported.

To account for delays in the reporting of cases, the variable adjwgt is included in the data set. This variable may be used to weight each case on the data set and obtain adjusted case counts. For example, summing adjwgt for cases would estimate the number of cases diagnosed through the time period covered by the data set that will eventually be reported to CDC. To use this variable, select the adjustment weight option from the Tools menu. Once you turn the option on, all subsequent tabulations will be adjusted for reporting delay. The adjustment weight and resulting tabulations are not reliable for cases diagnosed during the most recent 6 to 9 months.

Return to Manual

Effect of CD4 Reporting on AIDS Case Trends

As a result of the case definition change in 1993, trends in AIDS case counts showed an artifactual peak early in 1993, even after adjustment for reporting delay. To examine trends over time using a constant case definition, i.e., diagnoses of opportunistic illnesses that were included in the 1987 or the 1993 case definition, CDC developed methods that estimated incidence of 1987 or 1993 definition opportunistic infections for cases that met only the 1993 immunologic (CD4+) criteria. These estimates showed that the number of diagnoses of AIDS-defining opportunistic infections increased during 1992 and 1993 by approximately 2 percent and 3 percent, respectively (see Morbidity and Mortality Weekly Report, November 18, 1994). The temporary distortion of the AIDS incidence curve caused by the 1993 expansion of the AIDS case definition had almost entirely waned by 1996.

Return to Manual

Effect of Therapy on AIDS Incidence

Continuing the pattern first observed from 1995 to 1996, AIDS incidence decreased again from 1996 to 1997 and from 1997 to 1998. These decreases are mostly due to the effect of therapies for HIV infection and AIDS, which have altered the natural history of HIV infection and slowed progression to AIDS. AIDS incidence increasingly represents persons who were not diagnosed with HIV infection until they developed AIDS, persons who did not access treatment, or persons for whom treatment failed. Caution should be used when interpreting trends in AIDS incidence; the contribution of these effects to the AIDS incidence curve is currently being evaluated. See Morbidity and Mortality Weekly Report, September 19, 1997 and April 24, 1998.

Return to Manual

Early Reporting Dates

Before 1990, CDC occasionally received reports on patients before they met the CDC AIDS case definition. If such patients were later diagnosed with AIDS, the diagnosis date on their record (when they first met the CDC definition) would be after the report date (when CDC first received information about the patient). Such records should be excluded from certain analyses, such as survival analysis and analysis of reporting delay. CDC's AIDS surveillance data base no longer receives reports on patients who do not meet the AIDS case definition.

Return to Manual

Follow-up of Reported AIDS Cases

AIDS case records maintained at CDC contain all information reported to date from state and local health departments. As patients progress through their illness, additional conditions may be reported, or the patient's vital status may change. However, not all health departments have the resources to routinely follow-up patients for additional information. For this reason and because many patients move out of the reporting health department's jurisdiction, CDC records do not always contain all current information for each patient.

AIDS cases reports that do not include mode of HIV exposure information are routinely followed up by state and local health departments. As of December 1999, excluding cases which were not yet investigated, mode of exposure information has been identified for 78 percent of cases. Twenty-one percent of cases were closed with incomplete information because the patient died, declined interview, or was lost to follow-up; 1 percent of cases remained without a reported risk for HIV infection after complete investigation (see Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 1999;11 (no.2): 27). The demographic profile of persons who remain without risk information is more similar to that of other persons reported with AIDS than with the general U.S. population.

Return to Manual

Evaluation of AIDS Surveillance

Cases of AIDS may not be reported to CDC for a variety of reasons. The diagnostic tests needed to confirm the diagnosis of certain AIDS-indicator conditions may not be performed, or physicians and hospital personnel may fail to report cases to the health department. Further, some patients with HIV disease may be ill or die from diseases or conditions not included in the current AIDS surveillance definition or from causes unrelated to their HIV infection.

Both CDC and state and local health departments have commissioned a variety of studies to evaluate the completeness of AIDS surveillance. Most evaluation projects have used alternate data resources if they are independent of routine case finding, such as death certificates, hospital discharge records, and laboratory records. Individual records from these alternate sources have then been matched against records in AIDS surveillance data bases. If an alternative source is found to be a productive source of case reports, it may be added to routine case finding methods. Evaluation projects have varied in size and scope (e.g., varying numbers of ICD-9 codes from death certificates or computerized discharge records), geographic area covered, detection of both inpatient and outpatient cases, and time frames. In general, evaluation studies suggest that reporting of AIDS cases is fairly complete; but, depending on the setting and evaluation method used, the level of reporting completeness may vary. High prevalence areas for AIDS appear to have more complete reporting than low prevalence areas. Following implementation of active case finding under the 1987 case definition, with funding support from CDC, completeness of case reporting increased in most areas and was estimated to be more than 85 percent complete (see Journal of Acquired Immunodeficiency Syndrome, 1992;5:257-64 and American Journal of Public Health 1992;82:1495-99).

Return to Manual

Summary

Public health surveillance represents an ongoing and regular collection, analysis, interpretation, and application of health data for disease prevention and control. AIDS surveillance, like other national surveillance efforts, depends on health care providers and the state and local health departments and, thus, requires a balance between information needs versus practical limitations. AIDS surveillance in the United States represents an unprecedented public health enterprise and has achieved an unusually high degree of completeness. In addition, surveillance has changed as understanding of AIDS and HIV infection have grown. Users of the public information data set should be familiar with the characteristics of public health surveillance in general as well as with the evolution of AIDS surveillance.

Return to Manual

Last Modified: May 18, 2007
Last Reviewed: May 18, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
spacer CDC Black Logospacer Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer
spacerHHS Logo